Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes

NCT01928329 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT01928329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01928329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2013
Completion date
August 31, 2019
Enrollment
79 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

type i diabetes